Neuralink, a brain-computer interface (BCI) company founded by Elon Musk, has captured headlines for its potential to revolutionize how humans interact with technology. The company’s N1 device, with its intricate network of electrodes, aims to restore lost vision and mobility. This has investors wondering, will Neuralink go public?
Instagram | thefactpro | BCI technology implants a device in the brain to capture and translate electrical signals for controlling external devices.
BCI technology involves implanting a device in the brain to capture electrical signals. These signals are then translated by a computer, allowing for communication and control of external devices. Neuralink’s N1 device boasts over 1,000 electrodes, significantly more than competing technologies. This intricate design has the potential to provide a clearer picture of brain activity.
Another crucial component of Neuralink’s technology is the R1 surgical robot. Because the N1’s threads are incredibly thin, manual implantation is impossible. The R1 robot precisely inserts all 64 threads in under 15 minutes, minimizing surgical risks.
As of July 2024, Neuralink remains a private company. There haven’t been any official announcements about a Neuralink IPO. Considering that SpaceX, another Musk-owned company valued ten times higher than Neuralink, hasn’t gone public yet, a Neuralink IPO likely isn’t imminent.
But, when Neuralink does decide to go public, there will be signs. Public companies are required to file paperwork with the Securities and Exchange Commission (SEC) before offering shares. Investors following financial news will be notified well in advance of a Neuralink IPO.
Instagram | cyberjaya | Some investors speculate that Tesla might eventually acquire Neuralink.
Since Neuralink isn’t publicly traded, direct stock purchase isn’t possible. But for those eager to gain exposure to this innovative company, there are a few alternative options:
1. Invest in Alphabet (GOOG) – Google Ventures, Alphabet’s venture capital arm, is an early investor in Neuralink. By investing in Alphabet stock, you gain a minuscule, indirect stake in Neuralink’s future success.
2. Tesla (TSLA) – A Long Shot – While incredibly speculative, some investors wonder if Tesla might eventually get Neuralink. In 2022, Elon Musk remained noncommittal about merging the two companies. So, for now, this is a very distant possibility.
3. Waiting for the Neuralink IPO – The most straightforward approach is to wait for the eventual Neuralink IPO. But, this strategy requires patience, as the IPO could be years away. Additionally, investors considering this option should remember that IPOs can be volatile, and there’s no guarantee of immediate returns.
Regardless of whether you choose Alphabet, Tesla, or a future Neuralink IPO, the buying process is similar:
As a private company, Neuralink’s financial data isn’t publicly available. But, it’s safe to assume they aren’t profitable yet. Most medical device startups focus on research and development over immediate profits. Neuralink’s focus on groundbreaking technology comes at the expense of short-term financial gain.
Human trials for the N1 device are expected to begin in 2024. These initial trials will likely generate minimal revenue and focus on proving the concept’s viability. Profitability would likely come much further down the line, after successful large-scale trials and commercialization.
Image by Reuters | Neuralink’s technology shows great promise but remains in early development.
Investment decisions are personal and need careful consideration. While Neuralink’s technology holds immense promise, it’s still in the early stages of development. This inherently makes it a speculative investment. There’s a chance Neuralink could revolutionize healthcare, but there’s also a risk of failure.
Neuralink’s brain-computer interface technology has the potential to transform the lives of millions by restoring lost vision and mobility. But, the company is still private, and investors can’t directly buy Neuralink stock. Even if a Neuralink IPO happens in the future, it would be a high-risk investment.
For those interested in this area of innovation, there are alternative options like investing in Alphabet or the Global X Robotics & Artificial Intelligence ETF (BOTZ). Ultimately, the decision of whether to invest in Neuralink, or companies working in similar fields, depends on your individual risk tolerance and investment goals.
